PO:
Not recommended as first line medication; however some studies indicate it might be beneficial for patients with comorbid conditions.
Children 7 to 11 years: Limited data available; efficacy results variable: 1 to 3 mg/kg/day in single or divided doses.
Children ≥12 years and Adolescents: Initial: 25 to 75 mg/day at bedtime or in 2 to 3 divided doses; begin at the low end of range and gradually titrate; select patients may respond to 25 to 50 mg/day; maximum single dose: 150 mg; maximum daily dose: 300 mg/day.
Note: Controlled clinical trials have not shown TCAs to be superior to placebo for the treatment of depression in children and adolescents
Note: Controlled clinical trials have not shown TCAs to be superior to placebo for the treatment of depression in children and adolescents
Doxepin
Propranolol
Methazolamide
Lamotrigine
Topiramate
Phenytoin
Encainide
Phenobarbital